Artificial Intelligence

With the market set to double by 2030, the IAAPI Expo 2026 showcases a sector grappling with rapid growth, new tech, and the critical issue of safety.

MEXC Foundation and UNCB launch MEXCampus at UNSW, a new program teaching crypto trading to students, sparking a debate on opportunity versus risk.

Australia's TGA approves Claritas iPET™, an AI tool that promises faster, lower-dose PET scans, boosting hospital efficiency and patient safety.

With a massive ₹16,000 crore raised, Navi Finserv gathers industry leaders to showcase its tech-first model, aiming to reshape India's credit market.

Spatineo launches an AI-powered search tool to help GIS professionals find spatial data in minutes, not days, tackling a costly industry-wide problem.

Singapore's top agencies win awards for using geospatial AI to transform urban planning, transport, and water management, creating a more resilient city.

ENET launches a new 1.6T optical transceiver to tackle the data bottleneck in AI, but faces a market of giants and looming technological shifts.

Praxis Solutions' new WealthHawk platform uses AI to find clients at key life events, aiming to end cold calling and solve the organic growth puzzle.

Thinkific reports strong 2025 revenue and a return to profitability, betting its future on enterprise clients and its new 'Thinker' AI platform.

After its public debut, BBOT unveils exciting early data from three unique cancer drugs, including a first in pancreatic cancer, backed by a strong cash runway.

NeuroPace will present its RNS System at the Leerink conference, a key moment for the company to showcase its epilepsy treatment to top investors.

Digital accessibility leader AudioEye reports record 2025 earnings and unveils a next-gen platform promising enhanced legal protection for businesses.

aTyr Pharma heads to a crucial FDA meeting for its lung drug efzofitimod, which missed its main goal but showed significant patient quality-of-life gains.

Weebit Nano's advanced memory is at the heart of a South Korean national program aiming to revolutionize AI with ultra-low-power compute-in-memory chips.

The data center giant raises major capital to double its capacity, targeting the explosive growth in AI and cloud computing. Here's what it means.

NextCure accelerates its high-stakes ovarian cancer drug trial, but with cash dwindling, can it reach the finish line before time runs out?

As Hyperfine preps its 2025 results, investors and clinicians watch to see if its portable Swoop MRI can translate clinical promise into financial success.

Inuvo's stock faces uncertainty as a strategic pivot causes a steep Q4 revenue drop, betting its future on its privacy-focused IntentKey AI technology.

With a strong cash position, ArriVent pushes its lead lung cancer drug toward a mid-2026 data readout while building a new pipeline in ADCs.

Luminys Systems Corp. unveils its Vertical Experience Center, shifting from generic products to tailored AI security solutions for retail and education.